510(k) Report

510(k) · Cleared

Cleared

Latex Powder Free Surgical Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate; Latex Powder Free Surgical Gloves with Colloidal Oatmeal Tested for Use with Chemotherapy Drugs and Fentanyl Citrate

K260558510(k) TraditionalCleared Jul 28, 2026159-day reviewClass I21 CFR 878.4460

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hartalega NGC Sdn. Bhd. · KGO Surgeon'S Gloves

Cleared on Jul 28, 2026 as substantially equivalent to K214074 (Hartalega NGC Sdn. Bhd., 2022) and 1 other predicate after a 159-day review. Its family tree reaches back 2 generations to 2002.

Decided
Jul 28, 2026
Review
159 days
Class
Class I
Product code
KGO
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K022442 (2002). 3 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 2 generations backK022442 Powder Free Green Latex Surgical Gloves, Sterile with Aloe Vera and…Wrp Asia Pacific Sdn. Bhd. · 2002
  2. 1 generation backK032464 Aloetouch Powder Free Latex Surgical Gloves, Sterile, Coated with…Wrp Asia Pacific Sdn. Bhd. · 2003
  3. This deviceK260558 Latex Powder Free Surgical Gloves Tested for Use with Chemotherapy…Hartalega NGC Sdn. Bhd. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K022442Powder Free Green Latex Surgical Gloves, Sterile with Aloe Vera and Protein…Wrp Asia Pacific Sdn. Bhd.2002—
−1K032464Aloetouch Powder Free Latex Surgical Gloves, Sterile, Coated with Aloe Vera…Wrp Asia Pacific Sdn. Bhd.2003—
0 (this device)K260558Latex Powder Free Surgical Gloves Tested for Use with Chemotherapy Drugs and…Hartalega NGC Sdn. Bhd.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
202210
FIG. 1 — Lineage of K260558, 2002–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KGO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KGO device

  1. #1 K192328 JR.MEDIK Latex Surgeon’s Gloves Powder Freescore 15.2 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K214074Latex Powder Free Surgical Glove with Protein Labeling Claim of 50 Microgram or Less per…
Summary page 7
…: 21 CFR 878.4460 Reason for 510(k) Submission : New device PREDICATE DEVICE INFORMATION 1. 510(k) Number : K214074 Manufacturer : Hartalega NGC Sdn. Bhd. Trade Name (Proprietary Name) : Latex P…
Hartalega NGC Sdn. Bhd.2022—
*K032464Aloetouch Powder Free Latex Surgical Gloves, Sterile, Coated with Aloe Vera and with…
Summary page 7
…Product Code : KGO, LZC Regulation Number : 21 CFR 878.4460 2. 510(k) Number : K032464 Manufacturer : WRP Asia Pacific Sdn. Bhd. Trade Name (Proprietary Name) : Powd…
Wrp Asia Pacific Sdn. Bhd.2003—
†K143419Patient Examination GlovesHartalega NGC Sdn. Bhd.2015—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 2 companies; a new generation was cleared every 22.9 years on median.
  • None of the 3 ancestors has a recall.

How does its category compare?

All KGO devices

KGO Surgeon'S Gloves: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · KGO

1in 2025

2007: 102008: 22009: 32010: 62011: 112012: 72013: 62014: 72015: 122016: 92017: 122018: 72019: 112020: 152021: 142022: 62023: 142024: 22025: 12026 (partial year): 2
2007high 15 (2020) · low 1 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KGO

185in 2023

2007: 113 days median2009: 48 days median2010: 87 days median2011: 90 days median2012: 133 days median2013: 184 days median2014: 257 days median2015: 225 days median2016: 218 days median2017: 111 days median2018: 194 days median2019: 204 days median2020: 117 days median2021: 199 days median2022: 127 days median2023: 185 days median
2007high 257 (2014) · low 48 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KGO

2in 2023

2009: 152010: 12016: 22017: 12018: 82022: 22023: 2
2007high 15 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KGO

21in 2025

2007: 132008: 82009: 142010: 162011: 142012: 142013: 412014: 282015: 112016: 152017: 202018: 152019: 512020: 152021: 142022: 102023: 282024: 182025: 21
2007high 51 (2019) · low 8 (2008)2025

MAUDE reports naming product code KGO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200710113013
20082—08
20093481514
2010687116
20111190014
20127133014
20136184041
20147257028
201512225011
20169218215
201712111120
20187194815
201911204051
202015117015
202114199014
20226127210
202314185228
20242—018
20251—021
20262—0—

What is it indicated for?

Latex Powder Free Surgical Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate is made of natural rubber intended to be worn by operating personnel to protect surgical wound from contamination. It is also tested to be used against Chemotherapy Drugs and Fentanyl Citrate. The glove was tested for use with chemotherapy drugs and fentanyl citrate as per ASTM D6978 Standard Practice for Assessment of Resistance of Medical Gloves to Permeation…

Read the full statement (375 words)

Latex Powder Free Surgical Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate is made of natural rubber intended to be worn by operating personnel to protect surgical wound from contamination. It is also tested to be used against Chemotherapy Drugs and Fentanyl Citrate.

The glove was tested for use with chemotherapy drugs and fentanyl citrate as per ASTM D6978 Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs.

Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time in Minutes

Carmustine (3.3 mg/ml) 6.7

Cisplatin (1.0 mg/ml) > 240

Cyclophosphamide (20.0 mg/ml) > 240

Dacarbazine (10.0 mg/ml) > 240

Doxorubicin HCI (2.0 mg/ml) > 240

Etoposide (20.0 mg/ml) > 240

Fluorouracil (50.0 mg/ml) > 240

Methotrexate (25.0 mg/ml) > 240

Mytomycin C (0.5 mg/ml) > 240

Paclitaxel (6.0 mg/ml) > 240

Thiotepa (10.0 mg/ml) 11.5

Vincristine Sulfate (1.0 mg/ml) > 240

Fentanyl Citrate and Concentration Minimum Breakthrough Detection Time in Minutes

Fentanyl Citrate Injection (100mcg/2ml) >240

Caution: Testing showed a minimum breakthrough time of 6.7 minutes with Carmustine and 11.5 minutes with Thiotepa.

Warning: Do not use with Carmustine and Thiotepa

Latex Powder Free Surgical Gloves with Colloidal Oatmeal Tested for Use with Chemotherapy Drugs and Fentanyl Citrate is made of natural rubber intended to be worn by operating personnel to protect surgical wound from contamination. It is also tested to be used against Chemotherapy Drugs and Fentanyl Citrate.

The glove was tested for use with chemotherapy drugs and fentanyl citrate as per ASTM D6978 Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs.

Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time in Minutes

Carmustine (3.3 mg/ml) 7.7

Cisplatin (1.0 mg/ml) > 240

Cyclophosphamide (20.0 mg/ml) > 240

Dacarbazine (10.0 mg/ml) > 240

Doxorubicin HCI (2.0 mg/ml) > 240

Etoposide (20.0 mg/ml) > 240

Fluorouracil (50.0 mg/ml) > 240

Methotrexate (25.0 mg/ml) > 240

Mytomycin C (0.5 mg/ml) > 240

Paclitaxel (6.0 mg/ml) > 240

Thiotepa (10.0 mg/ml) 12.8

Vincristine Sulfate (1.0 mg/ml) > 240

Fentanyl Citrate and Concentration Minimum Breakthrough Detection Time in Minutes

Fentanyl Citrate Injection (100mcg/2ml) >240

Caution: Testing showed a minimum breakthrough time of 7.7 minutes with Carmustine and 12.8 minutes with Thiotepa.

Warning: Do not use with Carmustine and Thiotepa

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K260558: Latex Powder Free Surgical Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate; Latex Powder Free Surgical Gloves with Colloidal Oatmeal Tested for Use with Chemotherapy Drugs and Fentanyl Citrate.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K260558

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026